stocksfeed.ai
← Back to news feed

SLS overview

SLS
SELLAS Life Sciences Group, Inc
17.95
USD
+10.11 (+128.87%)since Nov 16, 2026

News about SLS

2 stories shown

U.S. stock futures rose on Wednesday ahead of the FOMC minutes, while Nvidia reported strong quarterly results and addressed leadership updates.

Benzinga
View original
SLSproduct launch

SELLAS Life Sciences stock tripled after its Phase 3 trial for the cancer vaccine GPS met its primary endpoint by reducing the risk of death by 41% in acute myeloid leukemia patients.

Benzinga
View original